Skip to content

The correlation of serum adenosine deaminase and tuberculin test for diagnosis of latent tuberculosis in close contact persons.

The correlation of serum adenosine deaminase and tuberculin test for diagnosis of latent tuberculosis in close contact persons.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20170207001
Enrollment
Unknown
Registered
2017-02-07
Start date
2015-11-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Latent pulmonary tuberculosis latent tuberculosis&#44

Interventions

Blood taken for serum ADA and tuberculin skin test were done.
Experimental No treatment
serum ADA and tuberculin skin test

Sponsors

None
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Persons older than 18 year old. 2. Close contact of tuberculosis patient (live in the same household at least 4 hours/wk with patient who had sputum AFB positive and/or sputum culture TB positive).

Exclusion criteria

Exclusion criteria: 1. Patient who had active pulmonary tuberculosis - Symptoms and signs which made doctor suspected of pulmonary tuberculosis (hemoptysis, cough for 2 wks, fever, weight loss) - sputum AFB or culture positive at least 1 time - Chest x-ray showed pulmonary tuberculosis 2. Previous treatment of pulmonary tuberculosis 3. Immunocompromised status eg. receiving immunosuppressive agents or chemotherapy or underlying disease of immunocompromised status or cancer

Design outcomes

Primary

MeasureTime frame
Mean serum ADA After tuberculin skin test at isolation unit Guisti and Galanti method

Secondary

MeasureTime frame
None None None

Countries

Thailand

Contacts

Public ContactWarangkana Keeratichananont

Songkhlanakarind hospital

tikrittirak@gmail.com0815890987

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026